Comparison of Epinephrine and Phenylephrine/Ketorolac With Regards to Pupil Size
Status:
Terminated
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the maintenance of intraoperative mydriasis during
cataract surgery between two drugs: epinephrine, which has routinely been used for decades,
and Omidria, a newly FDA approved combination drug of phenylephrine and ketorolac. Patients
undergoing cataract surgery that are enrolled in the trial will randomly receive one of the
drugs in one eye, and the other eye will receive the drug during the subsequent cataract
surgery.